INTERNATIONAL PATENT: IMMUNOGEN, INC., ZWEIDLER-MCKAY, PATRICK FILES APPLICATION FOR "ANTI-CD123 IMMUNOCONJUGATES FOR THE TREATMENT OF BLASTIC PLASMACYTOID CELL NEOPLASM"

GENEVA, Nov. 19 -- IMMUNOGEN, INC. (1 N. Waukegan RoadNorth Chicago, Illinois 60064), ZWEIDLER-MCKAY, Patrick (c/o ImmunoGen, Inc.1 N. Waukegan RoadNorth Chicago, Illinois 60064) filed a patent application (PCT/US2025/028687) for "ANTI-CD123 IMMUNOCONJUGATES FOR THE TREATMENT OF BLASTIC PLASMACYTOID CELL NEOPLASM" on May 09, 2025. With publication no. WO/2025/235918, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): IMMUNOGEN, INC. (1 N. Waukegan RoadNorth Chicago, Illinois 60064), ZWEIDLER-MCKAY, Patrick (c/o ImmunoGen, In...